Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genomic aberrations of myeloproliferative and myelodysplastic/myeloproliferative neoplasms in chronic phase and during disease progression.

International journal of laboratory hematology - 1 Apr 2015

Hahm C, Huh H J, Mun Y C, Seong C M, Chung W S, Huh J

Abstract excerpt

INTRODUCTION: Myeloproliferative neoplasms (MPN) and myelodysplastic/myeloproliferative neoplasms (MDS/MPN) may transform into secondary myelofibrosis (MF) or evolve into acute myeloid leukemia (AML). The genetic mechanisms underlying disease progression in MPN and MDS/MPN patients remain unclear. The purpose of this study was to investigate sequential genomic aberrations identified by single nucleotide...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chromosome Aberrations
Share to DNA Copy Number Variations

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Follow-Up Studies

Share to Janus Kinase 2

Share to Myelodysplastic-Myeloproliferative Diseases

Share to Myelodysplastic Syndromes

Share to Myeloproliferative Disorders

Share to Neoplasm Staging

Source

Identifiers

PMID: 24845343
DOI: 10.1111/ijlh.12257

Genes

JAK2
ABL1
BCR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genomic aberrations of myeloproliferative and myelodysplastic/myeloproliferative neoplasms in chronic phase and during disease progression.PMID 24845343Read ↗

Identification of genomic aberrations associated with disease transformation by means of high-resolution SNP array analysis in patients with myeloproliferative neoplasm.Semantic proximity Read ↗

Prevalence and prognostic impact of allelic imbalances associated with leukemic transformation of Philadelphia chromosome–negative myeloproliferative neoplasmsSemantic proximity Read ↗

Genome integrity of myeloproliferative neoplasms in chronic phase and during disease progression.Semantic proximity Read ↗

Genomics of myelodysplastic/myeloproliferative neoplasm.Semantic proximity Read ↗

Conventional Cytogenetic Analysis and Array CGH + SNP Identify Essential Thrombocythemia and Prefibrotic Primary Myelofibrosis Patients Who Are at Risk for Disease Progression.Semantic proximity Read ↗

Genetic and epigenetic alterations of myeloproliferative disorders.Semantic proximity Read ↗

Clinical characteristics and whole exome/transcriptome sequencing of coexisting chronic myeloid leukemia and myelofibrosis.Semantic proximity Read ↗

A case of a primary myelofibrosis with progression and related literature review of progression phase genetics.Semantic proximity Read ↗

Molecular landscape and clonal architecture of adult myelodysplastic/myeloproliferative neoplasms.Semantic proximity Read ↗

Immunophenotypic, cytogenetic, and mutational characterization of cell lines derived from myelodysplastic syndrome patients after progression to acute myeloid leukemia.Semantic proximity Read ↗

Genetic-pathologic characterization of myeloproliferative neoplasms.Semantic proximity Read ↗

Genomics of MPN progression.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.